Opus Genetics, Inc. — Operating Income by Fiscal Year

17 fiscal years, as filed with the SEC; every row links its evidence fact.

Cite as: FACTANKER, https://factanker.com/entity/8da2cd48-2d11-4389-b4dd-03bdb7ea38f3/serie/operating-income

Fiscal yearOperating IncomePeriodEvidence
FY 2025$-38.6M2025-01-01 – 2025-12-31evidence 0001140361-26-009247
FY 2024$-62.1M2024-01-01 – 2024-12-31evidence 0001140361-25-011410
FY 2023$-10.6M2023-01-01 – 2023-12-31evidence 0001140361-24-012399
FY 2022$18.2M2022-01-01 – 2022-12-31evidence 0001140361-23-014868
FY 2021$-22.7M2021-01-01 – 2021-12-31evidence 0001140361-22-011015
FY 2020$-20.0M2020-01-01 – 2020-12-31evidence 0001140361-21-008099
FY 2019$-4.2M2019-01-01 – 2019-12-31evidence 0001140361-21-008099
FY 2018$-20.5M2018-01-01 – 2018-12-31evidence 0001140361-19-004539
FY 2017$-17.4M2017-01-01 – 2017-12-31evidence 0001140361-18-012817
FY 2016$-16.4M2016-01-01 – 2016-12-31evidence 0001140361-17-009132
FY 2015$-18.3M2015-01-01 – 2015-12-31evidence 0001140361-16-057543
FY 2014$-13.3M2014-01-01 – 2014-12-31evidence 0001140361-15-011969
FY 2013$-79.3M2001-03-19 – 2014-03-31evidence 0001140361-14-020971
FY 2012$-70.5M2001-03-19 – 2013-03-31evidence 0001140361-13-019748
FY 2011$-63.9M2001-03-19 – 2012-03-31evidence 0001140361-12-023967
FY 2010$-10.3M2010-01-01 – 2010-12-31evidence 0001140361-12-016054
FY 2009$-6.5M2009-01-01 – 2009-12-31evidence 0001140361-12-016054
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).

Opus Genetics, Inc. — all facts · Revenue · Net Income